Has Arash Lalezary received payments from drug or device companies?

Yes. Drug and device makers reported $934 in general payments to Arash Lalezary across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arash Lalezary did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arash Lalezary come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arash Lalezary

Family Medicine · Bell Gardens, CANPI 1679513238

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $710 of the $934 with a category attached, or 76.0%. Eisai Inc. accounts for 82.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $771 and has fallen 97.3% since, to $20 in 2022.

$934in general payments, 2019–2025

Across 12 payments — averaging $77.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eisai Inc.$771
GSK$127
Agile Therapeutics, Inc.$35

$913,849in research payments, 2019–2025

Across 377 payments — averaging $2424.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GSK$227K
Alnylam Pharmaceuticals Inc.$122K
Endo Pharmaceuticals Inc.$102K
Eisai Inc.$95K
Mylan Inc.$93K
Braintree Laboratories, Inc.$89K
plus $186K from 5 others

What the payments were for

Travel & lodging$71076%
Food & beverage$22424%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eisai Inc.	5	$771
GSK	5	$127
Agile Therapeutics, Inc.	2	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Belviq$710

How this compares

$934 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metformin Er GastricMetformin Hcl	13	$23,801
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	16	$2,878
Metoprolol Succinate	33	$985
Simvastatin	68	$879
Lisinopril	85	$633
Albuterol Sulfate HfaAlbuterol Sulfate	13	$586
Levothyroxine Sodium	29	$475
Metformin Hcl	49	$430
Amlodipine Besylate	53	$421
Losartan Potassium	27	$356
Gabapentin	17	$347
Glipizide	21	$268
Pioglitazone Hcl	17	$244
Omeprazole	23	$239
Benazepril Hcl	22	$232

Paid to pharmacies, not to this prescriber.

Other family medicine in Bell Gardens

Sherly SoleimanEncino$1.2M
Pamela KushnerLos Angeles$1.2M
Sujata NarayanStanford$1.2M
Jeffrey UngerChino$906K
Alexander RivkinLos Angeles$866K
Scott HowellLos Angeles$793K
Derrick ButlerLos Angeles$692K
Sandra CalmanMontara$589K
Anthony JonesOakland$377K
Amira AyadBakersfield$360K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →